Evidence map›Paper›PMID 42256815›Full record

ArticleOncology letters2026

D-salicin induces oxidative stress-mediated ERK1/2 suppression and apoptosis in endometrial cancer cells.

Neziha Senem Ari, Ayşe Çakir Gündoğdu

Abstract read
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Neziha Senem AriDepartment of Histology and Embryology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya 43100, Türkiye.
Ayşe Çakir GündoğduDepartment of Histology and Embryology, Faculty of Medicine, Kütahya Health Sciences University, Kütahya 43100, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial cancer is a common gynecologic malignancy for which therapeutic options remain limited in advanced or treatment-resistant disease. Natural compounds that selectively perturb cancer-associated redox signaling and survival pathways may offer novel anticancer strategies. The present study investigated the anticancer effects of D-salicin in the endometrial adenocarcinoma-derived Ishikawa cell line, with a focus on oxidative stress and extracellular signal-regulated kinase (ERK)1/2 signaling, and assessed cancer selectivity using normal human dermal fibroblasts (HDF). D-salicin selectively reduced Ishikawa cell viability in a concentration-dependent manner while largely sparing HDF. This cytotoxic effect was accompanied by marked intracellular reactive oxygen species (ROS) accumulation, increased lipid peroxidation (MDA) and depletion of total glutathione (GSH), indicating induction of oxidative stress. Elevated oxidative burden was associated with caspase-3 activation and concentration-dependent suppression of ERK1/2 phosphorylation, both of which were attenuated by N-acetylcysteine (NAC) co-treatment. To determine redox dependence, NAC was incorporated as an antioxidant co-treatment. D-salicin induced a significant, concentration-dependent reduction in Ishikawa cell viability (P

Indexed as

apoptosisD-salicinendometrial cancerextracellular signal-regulated kinase 1/2N-acetylcysteineoxidative stressreactive oxygen species

Identifiers

PMID42256815
PMCPMC13238954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.